A Prospective Evaluation of Real‐World Experience with an Alzheimer's Blood‐Based Biomarker Panel in Memory Clinics: The CANTATE Project
A BBM panel specific to individual differential diagnostic considerations generally led to an increase in diagnostic confidence and in a minority resulted in a different diagnosis. These results suggest that this panel has some added value in daily clinical practice.
Authors
- Rik Ossenkoppele (ORCID: https://orcid.org/0000-0003-1584-7477)
- Afina W. Lemstra (ORCID: https://orcid.org/0000-0002-8933-3260)
- Thomas Claessen
- Harro Seelaar (ORCID: https://orcid.org/0000-0003-1989-7527)
- Marissa D. Zwan (ORCID: https://orcid.org/0000-0003-0879-2164)
- Yolande A.L. Pijnenburg (ORCID: https://orcid.org/0000-0003-2464-1905)
- Majon Muller
- Inge M.W. Verberk
- Sinthujah Vigneswaran
- Lisanne in ‘t Veld
- Rebecca Z. Rousset
- David H Wilson
- Lynn Boonkamp
- Charlotte E. Teunissen
- Wiesje M. van der Flier
- Argonde C. van Harten
Institutions
- Lund University (SE)
- Erasmus MC (NL)
- Amsterdam Neuroscience (NL)
- Quanterix (United States) (US)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103005
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00